TGFB1 and pulmonary fibrosis: We can therefore suggest that either mild-to-moderate healthy COVID-19 convalescents are not at higher risk of the development of pulmonary fibrosis, or that TGF-β is not an appropriate marker of pulmonary fibrosis risk in healthy subjects.